Gossamer Bio (GOSS) Short-term Investments: 2022-2025
Historic Short-term Investments for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to $171.3 million.
- Gossamer Bio's Short-term Investments fell 42.63% to $171.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $171.3 million, marking a year-over-year decrease of 42.63%. This contributed to the annual value of $248.4 million for FY2024, which is 6.00% down from last year.
- According to the latest figures from Q3 2025, Gossamer Bio's Short-term Investments is $171.3 million, which was down 8.21% from $186.6 million recorded in Q2 2025.
- Gossamer Bio's 5-year Short-term Investments high stood at $298.6 million for Q3 2024, and its period low was $125.1 million during Q2 2023.
- In the last 3 years, Gossamer Bio's Short-term Investments had a median value of $228.9 million in 2025 and averaged $216.3 million.
- Per our database at Business Quant, Gossamer Bio's Short-term Investments skyrocketed by 113.88% in 2024 and then crashed by 42.63% in 2025.
- Over the past 4 years, Gossamer Bio's Short-term Investments (Quarterly) stood at $143.7 million in 2022, then spiked by 83.93% to $264.3 million in 2023, then declined by 6.00% to $248.4 million in 2024, then tumbled by 42.63% to $171.3 million in 2025.
- Its Short-term Investments was $171.3 million in Q3 2025, compared to $186.6 million in Q2 2025 and $228.9 million in Q1 2025.